Recent increases in viral infections have led to a surge in sales of pharmaceutical products. After a slow start in January, February, and March pharma industry saw a sharp rise in the sale of anti-infectives, respiratory and pain medications due to the spread of flu, COVID-19, and other viruses.
According to the latest report from AWACS, India's pharmaceutical market experienced an 11% year-on-year growth in the fourth quarter of FY23 due to the surge of viral infections largely driven by increased sales of antibiotics, respiratory drugs, and analgesics. Anti-infectives, such as amoxycillin and clavulanic acid combinations, azithromycin, and hospital anti-infectives, saw a 33.7% increase in value and a 28% increase in volumes from February to March. This growth demonstrated that the spread of flu, Covid-19, and other viral infections significantly impacted the pharmaceutical industry.
Medical experts report that the respiratory medicines segment has seen tremendous growth in the past year, with value and volume growth of more than 50%. This growth was driven by cough syrups such as ambroxol, levosalbutamol, guaifenesin combinations, chlorpheniramine, and dextromethorphan combinations, budesonide, rota caps, and inhalers. Paracetamol and other analgesics also experienced a 20% value and 13% volume growth in the same period. The overall market grew 9.3% to ₹1.85 lakh crore in FY23, while the volume growth in the same period was 1.8%. GSK's Augmentin (amoxycillin and clavulanic acid) remained the market leader. Companies with strong anti-infective and respiratory portfolios, such as Cipla, Mankind, Macleods, Aristo, and Glenmark, saw more than 20% growth in March 2023.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article